URSODEOXYCHOLIC ACID MARKET ANALYSIS

Global ursodeoxycholic acid market growth can be hampered due to high costs associated with ursodeoxycholic acid. Ursodeoxycholic acid is used for the treatment of liver and gallbladder disorders but it is available at a very high price, which makes it unaffordable for many patients. The high production costs involved in manufacturing ursodeoxycholic acid contributes to its elevated prices. As ursodeoxycholic acid is synthesized from natural plant and bear bile extracts, the complex extraction and purification processes also increases its production costs. Low volume production of ursodeoxycholic acid adds to its unit costs. The exorbitant price of ursodeoxycholic acid treatment poses a significant barrier to its widespread adoption, especially in price-sensitive developing markets. Unless more cost-effective production techniques are developed or generic versions are introduced, the high costs will hamper the ursodeoxycholic acid market growth.

Market Opportunity- Increasing research funding for developing alternate treatments

Global ursodeoxycholic acid market can witness growth opportunities from increasing research funding for developing alternate treatments. Several government and private research organizations are funding research projects focusing on development of novel drug molecules and therapies that can replace ursodeoxycholic acid. This is mainly due to the limitations associated with ursodeoxycholic acid like its undesirable side-effect profile and high costs of therapy. Increasing research grants and investments in this domain have accelerated the pace of research. Several new drug candidates are under clinical trials that can potentially overcome the shortcomings of ursodeoxycholic acid. Successful development of effective and affordable alternate treatment options will open up new avenues of growth for ursodeoxycholic acid market players. The market is expected to transition towards these newer treatment forms in the future.